These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16777908)

  • 1. Class-dependent sequence alignment strategy improves the structural and functional modeling of P450s.
    Baudry J; Rupasinghe S; Schuler MA
    Protein Eng Des Sel; 2006 Aug; 19(8):345-53. PubMed ID: 16777908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking.
    Li W; Tang Y; Liu H; Cheng J; Zhu W; Jiang H
    Proteins; 2008 May; 71(2):938-49. PubMed ID: 18004755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural classification of the P450 superfamily based on consensus sequence comparison.
    Archakov AI; Degtyarenko KN
    Biochem Mol Biol Int; 1993 Dec; 31(6):1071-80. PubMed ID: 8193590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common active site architecture and binding strategy of four phenylpropanoid P450s from Arabidopsis thaliana as revealed by molecular modeling.
    Rupasinghe S; Baudry J; Schuler MA
    Protein Eng; 2003 Oct; 16(10):721-31. PubMed ID: 14600201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring structurally conservative blocks as universal templates for modeling eukaryotic cytochrome P450s.
    Tu Y
    Drug Metabol Drug Interact; 2012; 27(4):235-43. PubMed ID: 23096156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of coumarin by human P450s: a molecular modelling study.
    Lewis DF; Ito Y; Lake BG
    Toxicol In Vitro; 2006 Mar; 20(2):256-64. PubMed ID: 16157466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B
    Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicoverpa zea CYP6B8 and CYP321A1: different molecular solutions to the problem of metabolizing plant toxins and insecticides.
    Rupasinghe SG; Wen Z; Chiu TL; Schuler MA
    Protein Eng Des Sel; 2007 Dec; 20(12):615-24. PubMed ID: 18065401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of human P450 oxidoreductase structure by in silico mutagenesis and MD simulation.
    Flück CE; Mullis PE; Pandey AV
    Mol Cell Endocrinol; 2009 Dec; 313(1-2):17-22. PubMed ID: 19744540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B; Chow D; Hu M
    Drug Metab Rev; 2012 May; 44(2):192-208. PubMed ID: 22251142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of cytochrome P450 MoxA from Nonomuraea recticatena (CYP105).
    Yasutake Y; Imoto N; Fujii Y; Fujii T; Arisawa A; Tamura T
    Biochem Biophys Res Commun; 2007 Oct; 361(4):876-82. PubMed ID: 17679139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling of protein function regions.
    DeWeese-Scott C; Moult J
    Proteins; 2004 Jun; 55(4):942-61. PubMed ID: 15146492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology-based modeling of 3D structures of protein-protein complexes using alignments of modified sequence profiles.
    Kundrotas PJ; Lensink MF; Alexov E
    Int J Biol Macromol; 2008 Aug; 43(2):198-208. PubMed ID: 18572239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How similar are P450s and what can their differences teach us?
    Graham SE; Peterson JA
    Arch Biochem Biophys; 1999 Sep; 369(1):24-9. PubMed ID: 10462437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular definitions of fatty acid hydroxylases in Arabidopsis thaliana.
    Rupasinghe SG; Duan H; Schuler MA
    Proteins; 2007 Jul; 68(1):279-93. PubMed ID: 17427946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How inaccuracies in protein structure models affect estimates of protein-ligand interactions: computational analysis of HIV-I protease inhibitor binding.
    Thorsteinsdottir HB; Schwede T; Zoete V; Meuwly M
    Proteins; 2006 Nov; 65(2):407-23. PubMed ID: 16941468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of 3D atomic similarities and their use in the discrimination of small molecule protein-binding sites.
    Najmanovich R; Kurbatova N; Thornton J
    Bioinformatics; 2008 Aug; 24(16):i105-11. PubMed ID: 18689810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure and properties of CYP231A2 from the thermoacidophilic archaeon Picrophilus torridus.
    Ho WW; Li H; Nishida CR; de Montellano PR; Poulos TL
    Biochemistry; 2008 Feb; 47(7):2071-9. PubMed ID: 18197710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.